Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS
Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.
- Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR 200,000 capital increase.
- This is part of Atlas Special Opportunities, LLC’s EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.
- Following completion of the capital increase through the conversion of the convertible bonds, the total number of shares issued by Oxurion amounts to 1,089,578,053 outstanding ordinary shares carrying voting rights (compared to 1,022,343,629 outstanding ordinary shares previously).
- This number will be used as the denominator for the calculation of the percentages of shareholdings.